Pharmafile Logo
Pharmafocus logo
Advanced Search
Novartis Diagnostics Filiberto de Cal

Working Life: Novartis’ Filiberto de Cal

March 25, 2011
Business Services, Sales and Marketing Novartis, Working Life, recruitment

Filiberto de Cal is director of global marketing – new products at Novartis Diagnostics. Here he outlines his route into …

News

Merck drops oral anticoagulant

March 25, 2011
Merck, Pradaxa, Xarelto, anticoagulant, atrial fibrilation, vorapaxar

Merck has given the rights to its oral anticoagulant betrixaban back to Portola Pharmaceuticals after a review of its late …

News
Sanofi-Aventis headquarters

Sanofi signs ophthalmology research collaboration

March 25, 2011
Research and Development Fovea, Sanofi-Aventis, Vision Institute, ophthalmology

Sanofi-Aventis has penned a collaboration with one of the main eye disease research centres in Europe. The three-year agreement between …

News

Cephalon buys Gemin X for $225 million

March 24, 2011
Research and Development Cephalon, lung cancer

Cephalon is to acquire oncology specialist Gemin X and gain access to its cancer candidate obatoclax. The US biopharmaceutical firm …

News
aquapharm_bertrand_lehuu

Bertrand Lehuu joins Aquapharm

March 24, 2011
Research and Development appointment, research and development

Scottish marine biotechnology company Aquapharm Biodiscovery has appointed Bertrand Lehuu as senior VP – pharma business. Bertrand has almost 30 …

Appointment

The Real-Time Rep Becomes a Reality – Changing the Rules of Engagement with Customers

March 24, 2011
Sales and Marketing

The Real-Time Rep Defined The Real-Time Rep, no longer a fictitious ideal, is a salesperson who is able to:

Feature
Thought Leadership

Budget provides UK science incentives

March 24, 2011
Research and Development George Osborne, R&D tax credits, clinical trials

Chancellor George Osborne has unveiled tax incentives, new funding and moves to cut red tape for the life sciences sector …

News
Pharma on Facebook

Digital Pharma: European pharma and social media

March 24, 2011
Medical Communications, Sales and Marketing Digital Pharma blog, Facebook, Twitter, social media, youtube

European pharma is increasingly running local social media initiatives as companies expand on their first, centrally-driven, uses of the technology.Details …

Feature

FDA delays decision on Novartis’ COPD drug

March 23, 2011
Sales and Marketing COPD, Novartis, Onbrez Breezhaler, QAB149, bronchodilator, chronic obstructive pulmonary disease, indacterol

The FDA has delayed its licence decision on Novartis’ once-daily COPD treatment QAB149 by three months. The review process will …

News

Eisai marine sponge derived cancer drug approved in Europe

March 23, 2011
Sales and Marketing Cancer, Eisai, Halaven, Halichondria okadai, breast cancer, eribulin mesylate

Eisai’s injectible breast cancer drug Halaven has been approved by European regulators. The highly novel drug is made from a …

News

Kantar Health Names Andrew Miniuks Senior Director, Oncology Market Access

March 23, 2011

Kantar Health Names Andrew Miniuks Senior Director, Oncology Market AccessNEW YORK, March 22, 2011—Kantar Health, a leading healthcare-focused global consultancy …

News
Press release
GlaxoSmithKline office

GSK to fund schools science programme

March 23, 2011
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, King's College, school science

GlaxoSmithKline has followed its pledge to refund the tuition fees of UK graduates it takes on with a less direct …

News

Publicis buys Indian health advertising agency

March 23, 2011
Medical Communications Publicis Groupe, Publicis Life Brands Watermelon, Watermelon Healthcare Communications, healthcare communications agency, publicis

Publicis Groupe is to acquire a majority stake in a leading Indian healthcare advertising agency, Mumbai-based Watermelon Healthcare Communications. Publicis …

News

BMS skin cancer vaccine hits phase III target

March 23, 2011
Research and Development BMS, Bristol-Myers Squibb, advanced inoperable skin cancer, advanced melanoma, cancer drugs, cancer vaccine, ipilimumab

Bristol Myers Squibb’s cancer vaccine ipilimumab has increased overall survival in advanced melanoma patients. The therapy was being tested as …

News

Pharma manufacturing news in brief

March 22, 2011
Manufacturing and Production American Regent, Berkshire Hathaway, Cytovance, Intercell, Solagran, West Pharmaceutical Services, morphosys, pharma contract manufacturing

Lubrizol bought for $9.7 billion by Berkshire Hathaway, plus the latest pharma manufacturing and quality news. Berkshire Hathaway, run by …

News
Novartis vaccines research

Novartis increases stake in Chinese vaccines firm

March 22, 2011
Sales and Marketing China, emerging markets, vaccines

Novartis has continued its expansion into developing markets with the acquisition of a majority stake in a Chinese vaccines company. …

News
Roche's Swiss headquarters

Roche’s skin cancer drug passes mid-stage trial

March 22, 2011
Research and Development Curis, Roche, advanced basal cell carcinoma, skin cancer, vismodegib

Roche’s skin cancer candidate vismodegib has met its primary endpoint in a phase II trial. The drug is being tested …

News

Dendreon wins green light for Provenge production

March 22, 2011
Manufacturing and Production Cancer, Dendreon, FDA, Provenge, pharma manufacturing, prostate cancer vaccine, sipuleucel-T

US oncology specialist Dendreon has been boosted by the approval of additional production capacity for its therapeutic prostate cancer vaccine …

News

Lonza wins two biomanufacturing contracts

March 22, 2011
Manufacturing and Production Athera Biotechnologies, ENB-0040, Enobia Pharma, Lonza, PC-mAb, asfotase alfa, contract manufacturing, pharma, pharmaceuticals

Lonza has been awarded two contracts for biological drug candidates in quick succession, including a new deal that will make …

News

FDA and EMA join forces on quality-by-design

March 22, 2011
Manufacturing and Production EMA, FDA, QbD, Quality by Design, pharmaceutical marketing applications

The FDA has teamed up with the EMA on a new pilot programme that will allow parallel evaluation of marketing …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026